Status:
COMPLETED
Comparative Study of Perinatal Tissues for Clinical-Grade Mesenchymal Stem Cell Production and Cost-Effectiveness
Lead Sponsor:
Kayseri City Hospital
Conditions:
Regenerative Medicine
Stem Cell Banking
Eligibility:
FEMALE
18-45 years
Brief Summary
This observational laboratory-based study was conducted to evaluate the clinical feasibility and cost-effectiveness of mesenchymal stem cell (MSC) production from perinatal medical waste, including um...
Detailed Description
Perinatal medical waste, including the umbilical cord, amniotic fluid, amniotic membrane, and placenta, represents a promising and ethically acceptable source of mesenchymal stem cells (MSCs). Unlike ...
Eligibility Criteria
Inclusion
- Female participants only
- Age between 18 and 45 years
- Singleton, uncomplicated term pregnancies (≥37 weeks of gestation)
- Delivery by either elective cesarean section or spontaneous vaginal birth
- Written informed consent obtained prior to sample collection
Exclusion
- Presence of maternal infection at the time of delivery
- Known fetal malformations or chromosomal abnormalities
- Placental abnormalities (e.g., previa, abruption)
- Preterm labor (\<37 weeks)
- Any maternal comorbidity that may compromise tissue quality (e.g., uncontrolled diabetes, hypertension, autoimmune disease)
- Inability or unwillingness to provide informed consent
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT07169838
Start Date
January 1 2023
End Date
August 1 2025
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kayseri City Hospital
Kayseri, Kayseri, Turkey (Türkiye), 38130